EyePoint Pharmaceuticals
EYPT
EYPT
42 hedge funds and large institutions have $10.1M invested in EyePoint Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 5 closing their positions.
Holders
42
Holders Change
+6
Holders Change %
+16.67%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
12
Reduced
10
Closed
5
Calls
$2K
Puts
$169K
Net Calls
-$167K
Net Calls Change
-$193K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$2.34M |
2 |
2
Millennium Management
New York
|
$380K |
3 |
OAM
3
Oxford Asset Management
Oxford,
United Kingdom
|
$118K |
4 |
4
Squarepoint
New York
|
$100K |
5 |
5
Barclays
London,
United Kingdom
|
$57K |